Kim H, Gearing M, Mirra S S
VA Medical Center, Atlanta, GA.
Neurology. 1995 Sep;45(9):1768-70. doi: 10.1212/wnl.45.9.1768.
We investigated CA2/3 ubiquitin-immunoreactive neurites in 120 cases of diverse neurodegenerative diseases. This neuritic change occurred in 25 of 30 cases of Alzheimer's disease (AD) with coexistent Parkinson's disease (PD) changes, as well as two cases of PD and two cases of progressive supranuclear palsy. All 29 cases with neuritic change showed cortical Lewy bodies. Neuritic change was absent in 86 cases of neurodegenerative diseases without Lewy bodies, including 66 cases of pure AD. Thus, ubiquitin-immunoreactive CA2/3 neurites and cortical Lewy bodies, frequently coexist; this association appears to be independent of the presence or absence of coexistent pathologies, eg, AD. Moreover, in and of itself, nigral degeneration without Lewy bodies, such as that encountered in other (non-PD) movement disorders, apparently is not associated with CA2/3 neuritic change.
我们研究了120例不同神经退行性疾病中CA2/3泛素免疫反应性神经突。这种神经突变化出现在30例合并帕金森病(PD)改变的阿尔茨海默病(AD)中的25例,以及2例PD和2例进行性核上性麻痹中。所有29例有神经突变化的病例均显示有皮质路易体。在86例无路易体的神经退行性疾病中未发现神经突变化,包括66例单纯AD。因此,泛素免疫反应性CA2/3神经突和皮质路易体经常共存;这种关联似乎独立于是否存在并存的病理情况,如AD。此外,就其本身而言,无路易体的黑质变性,如在其他(非PD)运动障碍中所见到的,显然与CA2/3神经突变化无关。